SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-16-017050
Filing Date
2016-04-29
Accepted
2016-04-29 06:05:16
Documents
5
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A atra-defa14a_20160623.htm DEFA14A 27733
2 GRAPHIC gym4t2au551s000003.jpg GRAPHIC 32225
3 GRAPHIC gym4t2au551s000001.jpg GRAPHIC 59923
4 GRAPHIC gym4t2au551s000002.jpg GRAPHIC 71578
5 GRAPHIC gym4t2au551s000004.jpg GRAPHIC 33357
  Complete submission text file 0001564590-16-017050.txt   300756
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36548 | Film No.: 161602347
SIC: 2836 Biological Products, (No Diagnostic Substances)